Pivoting your products
When initial target indications or markets are no longer feasible, it is critical to pivot your products rapidly. How do we plan for pivoting to give minimal disruption and maximum success?
Feb 1, 2022
When initial target indications or markets are no longer feasible, it is critical to pivot your products rapidly. How do we plan for pivoting to give minimal disruption and maximum success?
Global CDMO @skpharmteco has appointed David Lowndes as COO. With 38 years of experience & world-class results, David will lead the company’s Supply Chain, Quality, Regulatory Affairs, R&D, IT, & Operational Excellence functions through a period of growth: https://www.lifescienceintegrates.com/sk-pharmteco-appoints-david-lowndes-as-coo/
A great summary of the "Vive la difference" discussion from #PharmaIntegrates by Kathryn Simpson (Kathryn Simpson Consulting), featuring insights from panellists from @TakedaPharma Top Stream Coaching & Consulting, @Pfizer & @LabcorpDrugDev
https://www.linkedin.com/pulse/diversity-equity-inclusion-necessary-success-life-sciences-simpson%3FtrackingId=lArlbkF%252FTyK2xcz3DSziVQ%253D%253D/?trackingId=lArlbkF%2FTyK2xcz3DSziVQ%3D%3D
#LifeScience
When initial target indications or markets are no longer feasible, it is critical to pivot your products rapidly. How do we plan for pivoting to give minimal disruption and maximum success?